Tumours | Methods for screening | Surveillance recommendations in carriers of germline SUFU variants (periodicity, age to start and to end) |
BCC | Dermatological examination | Annually
|
| ||
Medulloblastoma | Brain MRI without contrast agent except for the first MRI | Every 3–4 months during the first 3 years then every 6 months until 5 years |
Meningioma | Brain MRI | Every 3–5 years
|
| ||
Ovarian tumour | Pelvic ultrasound | Every 3 years, beginning at age 5 years |
Cardiac fibroma | Echocardiogram | At the time of diagnosis of GS, ideally in the first 6 months of life |
BCC, basal cell carcinoma; GS, Gorlin syndrome; MB, medulloblastoma.